CMANY
NTUS

Capital Management Associates (New York)’s Natus Medical Inc NTUS Stock Holding History

Capital Management Associates (New York)’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,000
Closed -$420K – 133
2017
Q4 		$420K Hold
11,000
– – 0.6% 80
2017
Q3 		$412K Buy
+11,000
New +$388K 0.59% 88

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Capital Management Associates (New York)'s NTUS Position: Q1 2018 in Review

Capital Management Associates (New York) sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 11,000 shares — an estimated $420K sold.

Capital Management Associates (New York) first reported a position in NTUS in Q3 2017 and held it in 2 quarters. The position peaked at $420K in Q4 2017. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

  • Capital Management Associates (New York) reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
  • Capital Management Associates (New York) sold 11,000 Natus Medical Inc shares in Q1 2018, an estimated $420K.
  • Capital Management Associates (New York) first reported a position in Natus Medical Inc in Q3 2017 and held it in 2 quarters.
  • Capital Management Associates (New York)'s Natus Medical Inc position peaked at $420K in Q4 2017.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Capital Management Associates (New York)'s 13F filing for Q1 2018, filed 3 May 2018.